Sickle Cell Gene Editing Therapy
Doctors at TriStar Centennial are participating in a national, clinical trial and using groundbreaking gene-editing therapy to help sickle cell patients in Tennessee.
Doctors at TriStar Centennial are participating in a national, clinical trial and using groundbreaking gene-editing therapy to help sickle cell patients in Tennessee.
0In this enlightening video, Dr. Esteva tackles 5 common myths surrounding cancer immunotherapy, providing clear, science-backed insights into what it can an…
An insurance company has denied newborn twins a one-time genetic treatment that could cure their spinal muscular atrophy — otherwise they are likely to die…
Key Points. UBA1 mutations were identified in 1% of MDS patients, enriched in patients with few myeloid mutations or established disease classification.Inf
Walgreens is expanding its specialty pharmacy services and investing in its capabilities as the company further grows its core pharmacy business to im
A video from Muhamed Baljevic (as part of Vanderbilt University Medical Center (VUMC)), posted on Jun 7, 2023.
Summary:. Liquid biopsies are emerging as powerful minimally invasive approaches that have the potential to solve several long-standing problems spanning the continuum of cancer care:…
Mayo Clinic’s PragMMatic Study Accruing Newly Diagnosed Multiple Myeloma Patients A new clinical trial administered by the Mayo Clinic, the PragMMatic Study, is now accruing newly…
Drugs in R&D – Mitomycin C (MMC) is an antitumor agent that is often administered intravesically to treat bladder cancer. Pharmacologically optimized studies have suggested…
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in…
Bispecific antibodies (BsAbs) create an immunologic synapse between T cells and malignant cells, via T-cell surface marker CD3 and a tumor cell surface marker, activating…